Detalhe da pesquisa
1.
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers.
Br J Cancer
; 129(8): 1327-1338, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37620410
2.
Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells.
Int J Mol Sci
; 24(21)2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37958662
3.
Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures.
Neurooncol Adv
; 3(1): vdab103, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34595478